Based on this YouTube video's total view count of 187K views and industry-standard rates, the estimated total earning is $131 - $375 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore We Can Cure Ebola! (Mostly—Which Is Better Than Rarely) | SciShow News with 187,530 views, 9,529 likes, and 589 comments. Experience the impact of this video content that has captured audience attention.

We’ve made a lot of progress recently in curing two deadly diseases that have been difficult to treat! Hosted by: Hank Green SciShow has a spinoff podcast! It's called SciShow Tangents. Check it out at http://www.scishowtangents.org ---------- Support SciShow by becoming a patron on Patreon: https://www.patreon.com/scishow ---------- Huge thanks go to the following Patreon supporters for helping us keep SciShow free for everyone forever: Adam Brainard, Greg, Alex Hackman, Sam Lutfi, D.A. Noe, Piya Shedden, KatieMarie Magnone, Scott Satovsky Jr, Charles Southerland, Patrick D. Ashmore, charles george, Kevin Bealer, Chris Peters ---------- Looking for SciShow elsewhere on the internet? Facebook: http://www.facebook.com/scishow Twitter: http://www.twitter.com/scishow Tumblr: http://scishow.tumblr.com Instagram: http://instagram.com/thescishow ---------- Sources: Ebola https://www.who.int/health-topics/ebola/ https://clinicaltrials.gov/ct2/show/NCT03719586 https://www.wired.com/story/ebola-is-now-curable-heres-how-the-new-treatments-work/?verso=true https://www.wired.com/story/an-ebola-vaccine-gets-its-first-real-world-test/ https://www.niaid.nih.gov/news-events/clinical-trial-investigational-ebola-treatments-begins-democratic-republic-congo https://www.sciencedirect.com/science/article/pii/S2589004219302287 https://www.sciencedirect.com/science/article/pii/S1473309918303979 Tuberculosis https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs https://www.washingtonpost.com/health/new-antibiotic-approved-for-drug-resistant-tuberculosis/2019/08/14/559d069a-bde6-11e9-9b73-fd3c65ef8f9c_story.html https://www.nytimes.com/2019/08/14/health/tuberculosis-xdr-tb-cure.html https://www.nature.com/articles/d41586-019-02464-0 https://www.cdc.gov/tb/topic/drtb/default.htm https://www.wsj.com/articles/fda-approves-new-pill-for-drug-resistant-tb-11565822369 https://www.tballiance.org/news/pa-824-has-new-generic-name-pretomanid Images: https://commons.wikimedia.org/wiki/File:GS-5734_structure.png https://commons.wikimedia.org/wiki/File:Pretomanid.svg https://www.istockphoto.com/vector/doctor-giving-medical-prescription-gm954744994-260678468 https://www.istockphoto.com/vector/six-types-of-viruses-on-white-background-gm838082782-136418499 https://www.istockphoto.com/photo/ebola-virus-gm509721629-45986612 https://www.istockphoto.com/photo/secondary-tuberculosis-in-lungs-and-close-up-view-of-mycobacterium-tuberculosis-gm949160140-259112180 https://www.videoblocks.com/video/fireball-transition-1080p-seunpvjpgjdkmikul

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.